Skip to main content

Silexion Therapeutics Corp 8-K, filed Sep 25, 2026

Silexion Therapeutics Corp (SLXN)

8-K 2026-09-25 For: 2026-09-25
View Original
Added on September 25, 2026

About this 8-K

Silexion Therapeutics Corp filed this 8-K on September 25, 2026.

At its September 23, 2026 meeting, Silexion Therapeutics Corp shareholders rejected a 175,000,000-share authorized capital increase and authorization of a 1-for-15 reverse share split. AI summary

Items reported

  • Item 5.07: Shareholder vote results